In cancer cells the interaction between Ship2-Sam and EphA2-Sam is expected to produce mainly pro-oncogenic effects, because Ship2 enhances the ligand-independent pro-migratory function of EphA2 and decreases its ligand-dependent tumor suppressor roles12. This evidence concerns the gene INPPL1 and cancer.